NCT02266485View on ClinicalTrials.gov

Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

September 30, 1998

Conditions
Healthy
Interventions
DRUG

BIBB 515 BS

DRUG

Pravastatin

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY